Navigation Links
Dynatronics Introduces New DynaPro Spinal Health System and X5 'Turbo'

SALT LAKE CITY, April 17 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced the introduction of two new products: the DynaPro Spinal Health System for treating back pain and the Dynatron X5 "Turbo" soft-tissue oscillation therapy unit.

"The new DynaPro Spinal Health System uses a four-phase treatment regimen combining the benefits of decompression with light therapy, core-stabilization exercises and nutrition," said Larry K. Beardall, executive vice president of sales and marketing. "Decompression therapy has been shown effective in relieving pain associated with a host of back problems including herniated discs, degenerative disc disease, sciatica and pinched nerves."

In addition to offering the most comprehensive approach to the effective treatment of many of the most common causes of back and neck pain, the DynaPro Spinal Health System incorporates a state-of-the-art marketing and patient- awareness program to help practitioners promote this proven, non-surgical pain relief treatment. With Dynatronics' revolutionary "Play Before You Pay" program, practitioners are able to "test drive" the concept by pre-marketing treatments prior to purchasing the system.

Another new product introduced this month is also being well received by the rehabilitation market. The new Dynatron X5 "Turbo" is three times more powerful than the original X5 device. It creates an electrostatic field within the patient that results in a highly effective treatment for acute as well as chronic pain. Soft-tissue oscillation therapy has proven to be very effective in the treatment of various orthopedic and sports injuries, and is gaining popularity in sports medicine.

"We notice immediate reductions in acute edema and joint stiffness," reported Mike Cembellin, Director of Sports Medicine, Santa Clara University. "The results from the X5 are impressive."

"We believe there is remarkable potential for both these new products," added Beardall. "The demand they will generate is expected to raise our fourth quarter results higher than previously anticipated."

Initial shipments of the new DynaPro Spinal Health System and the X5 "Turbo" have begun this month.

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, pain management, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets.

This press release contains forward-looking statements. Those statements include references to the company's expectations of future events. Actual results may vary from the views expressed in the forward-looking statements, including but not limited to references to efficacy of treatments, potential for the new products, expectations concerning operating results ahead of previous expectations. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, FDA clearance of new products, and the risk factors listed from time to time in the company's SEC reports, including, but not limited to the report on Form 10-KSB for the year ended June 30, 2007 and subsequent quarterly reports.

SOURCE Dynatronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dynatronics Introduces New Synergie Elite Aesthetic Line
2. Dynatronics Acquisitions Increase Sales 100 Percent in Second Quarter
3. Dynatronics to Release Second Quarter Results Thursday, February 14, 2008; Conference Call Set for 4:30 p.m. ET
4. Dynatronics Announces $250,000 Increase in Stock Buyback Program
5. Dynatronics Acquisitions Increase Sales 91 Percent in First Quarter
6. Dynatronics to Release First Quarter Results Monday, November 19, 2007; Conference Call Set for 1:30 p.m. ET
7. Dynatronics Adds Three Additional Direct Sales Reps
8. Dynatronics Announces Strong Fourth Quarter Profit
9. GHX Introduces NuVia(TM), an Artificial Intelligence-based Technology That Enables a New Approach to Content Management for Healthcare Providers
10. Mediware Introduces Comprehensive Vision for Blood Center Technology
11. Polar Introduces Cost-Effective Solution to Reduce Heart Rate Data Cross-Talk
Post Your Comments:
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... It’s ... has a tattoo — a number even greater among Millennials (a whopping one in ... are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... 01, 2015 , ... The importance of volumetric breast density ... of numerous abstracts accepted for presentation here, at the 101st Annual Radiology Society ... the use of Volpara Solutions’ quantitative breast imaging software tools for providing breast ...
(Date:12/1/2015)... Diego, CA (PRWEB) , ... December 01, 2015 ... ... and scale , Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro ... mobile imaging results enhancements at the Radiological Society of North America (RSNA) 2015 ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... it has been awarded a fixed price per sprint agile development contract to ... at $34 million over five years, provides software engineering, infrastructure, as well as ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Dec. 1, 2015  Six months of adjunctive metformin therapy ... 1 diabetes, according to new research from T1D Exchange ... may have a beneficial effect on measures of obesity, including ... of the Journal of the American Medical Association , ... effect of metformin on overweight and obese adolescents with type ...
(Date:12/1/2015)... 1, 2015 During the recent 2015 ... San Francisco, CA , Medinol Ltd. continued ... marketplace. During a satellite symposium, "The BioNIR eDES: ... Minimize Restenosis", a renowned physician panel discussed the ... CoCr Coronary Stent System and the Medinol eDES ...
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
Breaking Medicine Technology: